These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1931447)
41. [Chemotherapy of malignant tumors]. Ehrhart H Munch Med Wochenschr; 1973 May; 115(18):814-32. PubMed ID: 4800214 [No Abstract] [Full Text] [Related]
42. [Current trends in the chemotherapy of cancer]. Silva-Sosa M Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758 [No Abstract] [Full Text] [Related]
43. [Chemotherapy of malignant tumors]. Witte S Internist (Berl); 1968 Sep; 9(9):365-75. PubMed ID: 4918656 [No Abstract] [Full Text] [Related]
44. Pharmacologic aspects of the chemotherapy of solid tumors. DeVita VT; Rall DP Pharmacol Physicians; 1968 Sep; 2(9):1-6. PubMed ID: 5743792 [No Abstract] [Full Text] [Related]
45. Chemotherapy of solid tumors. Alberto P Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168 [No Abstract] [Full Text] [Related]
47. Update: the potential for chemosensitization of alkylating agents by nitroimidazoles. Mulcahy RT Oncology (Williston Park); 1988 Dec; 2(12):17-24, 27, 30-1 passim. PubMed ID: 3079289 [TBL] [Abstract][Full Text] [Related]
48. [Structure and mode of action of alkylating agents used in the therapy of neoplastic diseases]. Borresen HC Nord Med; 1969 Jan; 81(3):65-72. PubMed ID: 5767356 [No Abstract] [Full Text] [Related]
49. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs]. Bollag W Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076 [No Abstract] [Full Text] [Related]
50. Cancer chemotherapy in man. Wright JC; Madden RE Rev Surg; 1974; 31(4):217-37. PubMed ID: 4850859 [No Abstract] [Full Text] [Related]
51. [Current status and prospects of the clinical chemotherapy of tumorous diseases]. Perevodchikova NI Vestn Akad Med Nauk SSSR; 1986; (5):3-8. PubMed ID: 2425507 [No Abstract] [Full Text] [Related]
52. Drug resistance in cancer. Curt GA; Clendeninn NJ; Chabner BA Cancer Treat Rep; 1984 Jan; 68(1):87-99. PubMed ID: 6198082 [No Abstract] [Full Text] [Related]
53. [Quantitative evaluation of the efficacy of antineoplastic agents]. Karavainova MKh Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886 [No Abstract] [Full Text] [Related]
54. [Adverse events and those managements of alkylating agents]. Matsuoka H Nihon Rinsho; 2015 Feb; 73 Suppl 2():139-42. PubMed ID: 25831738 [No Abstract] [Full Text] [Related]
55. SPI and SPG in the treatment of advanced malignant lesions. Grewal TS; Samual KC; Sachdev DL; Rastogi DC Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546 [No Abstract] [Full Text] [Related]
56. [Aimed chemotherapy of malignancies]. Andrysek O Cas Lek Cesk; 1974 Jul; 113(28):850-3. PubMed ID: 4848005 [No Abstract] [Full Text] [Related]
57. [Drug therapy of neoplasms]. Witschi H Union Med Can; 1972 Mar; 101(3):500-2. PubMed ID: 5013473 [No Abstract] [Full Text] [Related]
58. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Teicher BA; Herman TS; Holden SA; Wang YY; Pfeffer MR; Crawford JW; Frei E Science; 1990 Mar; 247(4949 Pt 1):1457-61. PubMed ID: 2108497 [TBL] [Abstract][Full Text] [Related]
59. Drugs for the cancer surgeon. Watt J J R Nav Med Serv; 1969; 55(3):200-23. PubMed ID: 4903363 [No Abstract] [Full Text] [Related]